Bvf Inc has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $3.34 Billion distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $1.09B, Kymera Therapeutics, Inc. with a value of $208M, Revolution Medicines, Inc. with a value of $193M, 4 D Molecular Therapeutics, Inc. with a value of $125M, and Gh Research PLC with a value of $111M.

Examining the 13F form we can see an decrease of $480M in the current position value, from $3.82B to 3.34B.

Bvf Inc is based out at San Francisco, CA

Below you can find more details about Bvf Inc portfolio as well as his latest detailed transactions.

Portfolio value $3.34 Billion
Healthcare: $3.34 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $3.34 Billion
  • Prior Value $3.82 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 3 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.